Fig. 2From: Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositisSerum lipid species in patients with polymyositis or dermatomyositis before and after immunosuppressive treatment. PC, phosphatidylcholine; PE, phosphatidylethanolamine; LPC, lysophosphatidylcholine; TG, triacylglycerol. Results are expressed as percentage area (Area %) (mean ± SE): *p < 0.05 for after treatment versus before treatmentBack to article page